Comparison of New‐Onset Peripheral Artery Disease in Patients With Type 2 Diabetes Exposed to Sodium–Glucose Cotransporter‐2 Inhibitors, Dipeptidyl Peptidase‐4 Inhibitors, or Glucagon‐Like Peptide‐1 Agonists: A Population‐Based Cohort Study

Comparison of New‐Onset Peripheral Artery Disease in Patients With Type 2 Diabetes Exposed to Sodium–Glucose Cotransporter‐2 Inhibitors, Dipeptidyl Peptidase‐4 Inhibitors, or Glucagon‐Like Peptide‐1 Agonists: A Population‐Based Cohort Study

Background Sodium‐glucose cotransporter‐2 inhibitors (SGLT2Is), dipeptidyl peptidase‐4 inhibitors (DPP4Is), and glucagon‐like peptide‐1 receptor agonists have been associated with improved cardiovascular outcomes and prognosis. The comparative risks of new‐onset peripheral artery disease (PAD) betwe...

Full description

Saved in:
Bibliographic Details
Main Authors: Oscar Hou‐In Chou, Zhiyao Luo, Cheuk To Skylar Chung, Jeffrey Chan, Huixian Li, Ishan Lakhani, Sharen Lee, Dawnie Ho Hei Lau, Qingpeng Zhang, Tong Liu, Wing Tak Wong, Bernard Man Yung Cheung, Gregory Y. H. Lip, Fung Ping Leung, Gary Tse, Jiandong Zhou
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
amputation
cardiovascular disease
dipeptidyl peptidase‐4 inhibitors
glucagon‐like peptide‐1 receptor agonists
peripheral artery disease
sodium‐glucose cotransporter‐2 inhibitors
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.123.034175
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.123.034175

Similar Items